Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy Participants

MLA

Fan, Bin, et al. “Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy Participants.” Clinical Pharmacology in Drug Development, vol. 10, no. 1, Jan. 2021, pp. 99–109. EBSCOhost, https://doi.org/10.1002/cpdd.821.

APA

Fan, B., Dai, D., Cohen, M., Xu, H., Yin, F., Nagaraja, R., Mobilia, M., Almon, C., Basile, F. G., & Yang, H. (2021). Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy Participants. Clinical Pharmacology in Drug Development, 10(1), 99–109. https://doi.org/10.1002/cpdd.821

Chicago

Fan, Bin, David Dai, Marvin Cohen, Huansheng Xu, Feng Yin, Raj Nagaraja, Michelle Mobilia, Caroline Almon, Frank G. Basile, and Hua Yang. 2021. “Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy Participants.” Clinical Pharmacology in Drug Development 10 (1): 99–109. doi:10.1002/cpdd.821.